Alternative approaches to valuing intangible health losses: the evidence for multiple sclerosis.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Health Economics

• Publication date

  1998-08-01

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1016/S0167-6296(97)00025-8PMID 10180927
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis.

  1999cited by this paper
• A comprehensive assessment of the cost of multiple sclerosis in the United States

  1998cited by this paper
• Valuing Health for Policy: An Economic Approach

  1996cited by this paper
• Valuing health care

  1996cited by this paper
• A Reference Lottery Metric for Valuing Health

  1996cited by this paper
• Valuing health care: Utility assessment for estimating quality-adjusted life years

  1995cited by this paper
• Variation in patient utilities for outcomes of the management of chronic stable angina. Implications for clinical practice guidelines. Ischemic Heart Disease Patient Outcomes Research Team.

  1995cited by this paper
• Valuing health for policy : an economic approach

  1995cited by this paper
• Valuing health care : costs, benefits, and effectiveness of pharmaceuticals and other medical technologies

  1995cited by this paper
• Variation in Patient Utilities for Outcomes of the Management of Chronic Stable Angina: Implications for Clinical Practice Guidelines

  1995cited by this paper
• Valuing health care: Valuing health care benefits in money terms

  1995cited by this paper
• Treatment of Multiple Sclerosis: Trial Design, Results, and Future Perspectives

  1994cited by this paper
• Developing and Testing a Multimedia Presentation of a Health-state Description

  1994cited by this paper
• Comparison of the Rating Scale and the Standard Gamble in Measuring Patient Preferences for Outcomes of Gallstone Disease

  1994cited by this paper
• Epidemiology of multiple sclerosis in U.S. veterans: V. Ancestry and the risk of multiple sclerosis

  1993cited by this paper
• Update on multiple sclerosis therapy.

  1993cited by this paper
• Understanding patients' decisions. Cognitive and emotional perspectives.

  1993cited by this paper
• Multiple Sclerosis: A Literature Review

  1993cited by this paper
• Multiple sclerosis: Does epidemiology contribute to providing etiological clues?

  1993cited by this paper
• The value of risks to life and health

  1993influential reference
• Revised estimate of the prevalence of multiple sclerosis in the united states

  1992cited by this paper
• The Natural History of Multiple Sclerosis

  1992cited by this paper
• The effect of information on health risk valuations

  1992cited by this paper
• Pricing environmental health risks: survey assessments of risk-risk and risk-dollar trade-offs for chronic bronchitis☆

  1991cited by this paper
• Neuro‐ophthalmology

  1991cited by this paper
• Utility Functions That Depend on Health Status: Estimates and Economic Implications

  1990cited by this paper
• The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course.

  1989cited by this paper
• The use of QALYs in health care decision making.

  1989cited by this paper
• The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability.

  1989cited by this paper
• Utility approach to measuring health-related quality of life.

  1987cited by this paper
• Measurement of health state utilities for economic appraisal.

  1986cited by this paper
• Weights for Scoring the Quality of Well-being Instrument Among Rheumatoid Arthritics: A Comparison to General Population Weights

  1986cited by this paper
• Epidemiology of multiple sclerosis in U.S. veterans

  1979cited by this paper
• Cultural influences on the incidence and pattern of disease.

  1975cited by this paper
• Survey of current business

  year unknowncited by this paper

• Explaining the long-term care insurance puzzle: The role of preferences for correlation and for quality of life over wealth.

  2025cites this paper
• Health Risk and the Value of Life.

  2025cites this paper
• The effect of health on the marginal utility of consumption: Evidence based on household consumption expenditure

  2025cites this paper
• The Risk Protection Value of Moral Hazard

  2025cites this paper
• Optimal self‐insurance with genetic testing and state‐dependent utility

  2024cites this paper
• A user’s guide to economic utility functions

  2024cites this paper
• Moral Hazard in Loss Reduction and State-Dependent Utility

  2024cites this paper
• Patient Preferences for Lung Cancer Interception Therapy

  2023cites this paper
• When Patients are Assailants: Valuing Occupational Risks in Health Care

  2023cites this paper
• No Time to Waste: An Appraisal of Value at the End of Life.

  2022cites this paper
• Prevention, treatment, and palliative care: The relative value of health improvements under alternative evaluation frameworks.

  2022cites this paper
• Valuing non-marginal changes in mortality and morbidity risk.

  2022cites this paper
• Health-Dependent Preferences, Consumption, and Insurance

  2022cites this paper
• An Empirical Analysis of Health-Dependent Utility on SHARE and ELSA Data

  2022cites this paper
• Vaccination under pessimistic expectations in clinical trials and immunization campaigns

  2022cites this paper
• Diversification and risk attitudes toward two risks

  2022cites this paper
• Hesitancy Toward a COVID-19 Vaccine

  2021cites this paper
• Willingness to pay for reductions in health risks under anticipated regret.

  2021cites this paper
• Valuing COVID-19 Mortality and Morbidity Risk Reductions in U.S. Department of Health and Human Services Regulatory Impact Analyses

  2021cites this paper
• Self-insurance and saving under a two-argument utility framework

  2021cites this paper
• A fresh look at primary prevention for health risks.

  2021cites this paper
• Production and hedging under correlated price and background risks

  2021cites this paper
• Misperceptions of Uncertainty and Their Applications to Prevention

  2020cites this paper
• Theoretical bounds on the value of improved health.

  2020cites this paper
• Hesitancy Towards a COVID-19 Vaccine and Prospects for Herd Immunity

  2020cites this paper
• How Does Health Status Affect Marginal Utility of Consumption? Evidence from China

  2020cites this paper
• Wellbeing measures of mortality risks: life-cycle contradictions and ordinal index challenges

  2020cites this paper
• Does the Value per Statistical Life vary with age or baseline health? Evidence from a compensating wage study in France

  2020cites this paper
• Incentive and welfare effects of correlated returns

  2020cites this paper
• When Money Matters More: Long‐Term Illness and the Income/Life Satisfaction Slope

  2020cites this paper
• Willingness to Pay for Health Improvements Using Stated Preferences: Prevention Versus Treatment.

  2020cites this paper
• Using non-marginal risk reductions to elicit VSL

  2019cites this paper
• Health and consumption preferences; estimating the health state dependence of utility using equivalence scales

  2019cites this paper
• Incentive and Welfare Effects of an Idiosyncratic Interest Rate

  2019cites this paper
• The effect of financial risk on the demand for supplementary health insurance

  2019cites this paper
• Effet des préférences individuelles sur la réussite à long terme des incitations financières à la réalisation d’objectifs de santé

  2019cites this paper
• Measuring multivariate risk preferences in the health domain.

  2019cites this paper
• The Role of Optimism and Pessimism in the Substitution Between Primary and Secondary Health Prevention Efforts

  2019cites this paper
• The willingness to pay for health improvement under comorbidity ambiguity.

  2019cites this paper
• Utility functions for mild and severe health risks

  2019cites this paper
• Health Shocks and Subsequent Retiree Spending

  2018cites this paper
• Household Labor Supply and the Gains from Social Insurance.

  2018cites this paper
• Advantageous Selection, Moral Hazard, and Insurer Sorting on Risk in the U.S. Automobile Insurance Market.

  2018cites this paper
• Average willingness to pay for disease prevention with personalized health information

  2017cites this paper
• New findings from the time trade-off for income approach to elicit willingness to pay for a quality adjusted life year

  2017cites this paper
• Baseline risk and marginal willingness to pay for health risk reduction

  2017cites this paper
• Mortality Risk, Insurance, and the Value of Life*

  2017cites this paper
• The Role of Medical Expenditure Risk in Portfolio Allocation Decisions

  2017cites this paper
• A Stated Preference Approach to Assess whether Health Status Impacts on Marginal Utility of Consumption

  2017cites this paper
• Health and the Marginal Utility of Consumption : Estimating Health State Dependence using Equivalence Scales

  2017cites this paper
• Evaluating Willingness to Pay as a Measure of the Impact of Dyslexia in Adults

  2017cites this paper
• Extrapolating the Value Per Statistical Life Between Populations: Theoretical Implications

  2017cites this paper
• Valuing Non-fatal Health Risks: Monetary and Health-Utility Measures

  2017cites this paper
• Essays on the Economics of Insurance and Healthcare Markets

  2017cites this paper
• Behavioral Economics for Cost-Benefit Analysis: Benefit Validity When Sovereign Consumers Seem to Make Mistakes

  2017cites this paper
• Rational Benefit Assessment for an Irrational World: Toward a Behavioral Transfer Test1

  2016cites this paper
• The value of disease prevention vs treatment.

  2016cites this paper
• Valuing Reductions in Fatal Illness Risks: Implications of Recent Research.

  2016cites this paper
• The Value of Cancer Prevention vs Treatment

  2016cites this paper
• Three Essays on the Consumption Patterns of the Elderly

  2016cites this paper
• The value of risk reduction: new tools for an old problem

  2015influential citation
• Income, Health, and the Value of Preserving Options

  2015cites this paper
• Saving and perceived health risks

  2015cites this paper
• Approaches to valuing injury and mortality risk in transport assessments

  2015cites this paper
• Income, Health, and the Value of Preserving Options

  2015cites this paper
• Do preferences of drinker-drivers differ?

  2015cites this paper
• Tertiary Health Prevention and Saving

  2015cites this paper
• New Findings from the TTO for Income Approach to Elicit Willingness to Pay for a QALY

  2014cites this paper
• The value of risk reduction: new tools for an old problem

  2014influential citation
• Does Private Information Influence Automobile Insurance Purchase Decisions

  2014cites this paper
• Market failure in the pharmaceutical industry and how it can be overcome: the CureShare mechanism

  2014cites this paper
• The Pricing of Breakthrough Drugs: Theory and Policy Implications

  2014cites this paper
• Chapter 7 - The Value of Individual and Societal Risks to Life and Health

  2014cites this paper
• Disability and marginal utility of income: evidence from hypothetical choices.

  2014cites this paper
• Handbook of the economics of risk and uncertainty

  2014cites this paper
• Managing genetic tests, surveillance, and preventive medicine under a public health insurance system.

  2014cites this paper
• On Saving and Caring for Dependents

  2014cites this paper
• Long-term health investment when people underestimate their adaptation to old age-related health problems

  2013cites this paper
• How Does Medical Innovation Create Value? Health, Human Capital and the Labor Market

  2013cites this paper
• Demand for health risk reductions

  2013cites this paper
• Analyse économique des comportements de prévention face aux risques de santé

  2013cites this paper
• Prévention en santé et ambiguïté

  2013cites this paper
• Admissible utility functions for health, longevity, and wealth: integrating monetary and life-year measures

  2013cites this paper
• Kosten-Nutzen-Verhältnis als Rationierungskriterium

  2013cites this paper
• Admissible utility functions for health, longevity, and wealth: integrating monetary and life-year measures

  2013influential citation
• Cost Effectiveness in Low- and Middle-Income Countries

  2012cites this paper
• Empirical Analysis of Tort Damages

  2012cites this paper
• Essays in Residential Choice and Non-Market Valuation

  2012cites this paper
• More on the optimal demand for long-term care insurance

  2012cites this paper
• An experimental test of the concentration index.

  2012cites this paper
• Endogenous Patient Responses and the Consistency Principle in Cost-Effectiveness Analysis

  2012cites this paper
• What is a QALY Worth ? Admissible Utility Functions for Health , Longevity , and Wealth

  2012influential citation
• The utility of health and wealth.

  2012cites this paper
• Saving and perceived health risks

  2012influential citation
• The CureShare mechanism, the utility from health and wealth, and optimal monopolistic pricing of breakthrough drugs

  2011cites this paper
• La evaluación de enfermedades. Un enfoque de bienestar subjetivo

  2011cites this paper
• Experimental tests of multidimensional inequality measures

  2011cites this paper
• Expected Longevity and Demand for Clean Environment ∗

  2011cites this paper
• How Does Medical Innovation Create Value ?

  2011cites this paper
• Nonlinear Dynamics in an OLG Growth Model with Young and Old Age Labour Supply: The Role of Public Health Expenditure

  2011cites this paper